Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mytecit-L Tablet

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Levocetirizine (5mg) + Montelukast (10mg)

Overview Mytecit-L Tablet

Aller-Ease Plus tablets combine medications to alleviate allergic reactions. These reactions include nasal symptoms like runny or stuffy nose, sneezing, and itching, as well as eye irritation, swelling, and congestion. The medication also lessens airway inflammation, improving breathing. Dosage and duration are determined by your physician and should be followed precisely. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence or worsening. Inform your doctor of all other medications you're using, as interactions may occur. Common side effects include nausea, diarrhea, vomiting, dry mouth, headache, rash, flu-like symptoms, and tiredness. Most side effects are temporary. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until effects are known. Alcohol should be avoided due to increased drowsiness. Never self-medicate or share this medication. Adequate hydration is recommended. Disclose any kidney problems to your physician before starting treatment.

Primary Ingredients of Mytecit-L Tablet

There is no text provided to rephrase.

Uses of Mytecit-L Tablet

Managing allergic dermatitis | Alleviating allergic rhinitis symptoms | Treating seasonal allergic conjunctivitis

Major Benefits of Mytecit-L Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or splitting it. Mytecit-L Tablets can be administered with or without food, though consistent timing is recommended.

Common Side effects of Mytecit-L Tablet:

  • Nausea
  • Diarrhea
  • Dryness in mouth
  • Fatigue
  • Headache
  • Skin rash
  • Sleepiness
  • Vomiting
  • Upper respiratory tract infection
  • Sore throat
  • Fever
  • Abdominal pain
  • Increased liver enzymes

How to use Mytecit-L Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mytecit-L Tablets can be administered with or without food, though consistent timing is recommended.

How Mytecit-L Tablet works:

Aller-Ease Duo tablets combine levocetirizine and montelukast to alleviate allergic symptoms such as sneezing and nasal discharge. Levocetirizine, an antihistamine, counteracts histamine, a chemical mediator causing nasal congestion, eye watering, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotrienes, another inflammatory mediator. This dual action reduces airway and nasal inflammation, providing effective symptom relief.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Mytecit-L Tablet and alcohol. Physician consultation is recommended.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Mytecit-L Tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human studies are scarce.

Breast feedingBreast feedingUNSAFE

Lactation and Mytecit-L tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Mytecit-L Tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should use Mytecit-L Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Mytecit-L Tablets are contraindicated in individuals with severe kidney dysfunction.

LiverLiverCAUTION

Individuals with severe hepatic impairment should use Mytecit-L tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data regarding Mytecit-L tablet use in such patients is limited. Dosage alteration is not advised for those with mild to moderate liver dysfunction.

What if you forget to take Mytecit-L Tablet :

Should you forget a Mytecit-L Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mytecit-L Tablet

LabelValue
Developing Habits No.
Treatment Category Breathing

FAQs on Mytecit-L Tablet

Mytecit-L Tablets combine montelukast and levocetirizine to alleviate allergy symptoms. Levocetirizine, an antihistamine, reduces allergy-related chemicals, relieving runny nose, sneezing, watery eyes, and cough. Montelukast blocks leukotrienes, reducing airway and nasal inflammation, providing further symptom relief.
Mytecit-L Tablets commonly cause drowsiness. Avoid driving, operating machinery, or other activities requiring alertness unless your doctor approves. Refrain from alcohol and other central nervous system depressants (including cough/cold medicines, pain relievers, and sleep aids) to prevent excessive drowsiness and the risk of falls or accidents.
Continue taking Mytecit-L tablets as prescribed. Contact your doctor if you experience any side effects or if your allergy symptoms worsen.
Dry mouth is a possible side effect of Mytecit-L Tablets. To alleviate this, drink water frequently throughout the day and keep a glass by your bedside. Use lip balm as needed for dry lips.
Avoid alcohol while using Mytecit-L Tablet; alcohol consumption intensifies the medication's sleep-inducing effects.
Increasing your Mytecit-L Tablet dosage won't improve its effectiveness; it only increases the risk of side effects. For worsening symptoms, seek medical advice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Mytecit-L Tablet
105